Downregulation of miR-122 in the rodent and human hepatocellular carcinomas
about
MicroRNA-122 modulates the rhythmic expression profile of the circadian deadenylase Nocturnin in mouse liver.Inhibition of microRNA function by antimiR oligonucleotidesmicroRNA-122 as a regulator of mitochondrial metabolic gene network in hepatocellular carcinomaControlled expression of functional miR-122 with a ligand inducible expression systemThe liver-specific microRNA miR-122 controls systemic iron homeostasis in miceThe miR-17-5p microRNA is a key regulator of the G1/S phase cell cycle transitionAltered microRNA Expression Patterns in Hepatoblastoma PatientsMicroRNA-122 inhibits tumorigenic properties of hepatocellular carcinoma cells and sensitizes these cells to sorafenibDown-regulation of micro-RNA-1 (miR-1) in lung cancer. Suppression of tumorigenic property of lung cancer cells and their sensitization to doxorubicin-induced apoptosis by miR-1Elevated expression of the miR-17-92 polycistron and miR-21 in hepadnavirus-associated hepatocellular carcinoma contributes to the malignant phenotypeMethylation mediated silencing of MicroRNA-1 gene and its role in hepatocellular carcinogenesisRole of microRNA-155 at early stages of hepatocarcinogenesis induced by choline-deficient and amino acid-defined diet in C57BL/6 miceInterplay Between Metabolism and Oncogenic Process: Role of microRNAsHepatocellular carcinoma mouse models: Hepatitis B virus-associated hepatocarcinogenesis and haploinsufficient tumor suppressor genesThe role of microRNAs in human liver cancersmiR-122 is a unique molecule with great potential in diagnosis, prognosis of liver disease, and therapy both as miRNA mimic and antimirAdeno-associated virus-mediated microRNA delivery and therapeuticsMicroRNA, nutrition, and cancer preventionMicroRNAs as targets for dietary and pharmacological inhibitors of mutagenesis and carcinogenesisDiscovery of porcine microRNAs in multiple tissues by a Solexa deep sequencing approachMicroRNA signatures in liver diseasesGene expression and hepatitis C virus infectionTP53/MicroRNA Interplay in Hepatocellular CarcinomamiR-17-5p Promotes migration of human hepatocellular carcinoma cells through the p38 mitogen-activated protein kinase-heat shock protein 27 pathwayTranscriptional changes induced by the tumor dormancy-associated microRNA-190Tumor suppressor and hepatocellular carcinomamiR-190 Enhances HIF-Dependent Responses to Hypoxia in Drosophila by Inhibiting the Prolyl-4-hydroxylase FatigaThe cardiac transcription network modulated by Gata4, Mef2a, Nkx2.5, Srf, histone modifications, and microRNAsMiR-182 is up-regulated and targeting Cebpa in hepatocellular carcinomaMicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancerUltrasound-guided therapeutic modulation of hepatocellular carcinoma using complementary microRNAsMicroRNAs in cancer.MicroRNAs in nonalcoholic fatty liver disease: novel biomarkers and prognostic tools during the transition from steatosis to hepatocarcinoma.Sex-different and growth hormone-regulated expression of microRNA in rat liver.microRNA-122 abundance in hepatocellular carcinoma and non-tumor liver tissue from Japanese patients with persistent HCV versus HBV infection.miR-183 inhibits TGF-beta1-induced apoptosis by downregulation of PDCD4 expression in human hepatocellular carcinoma cells.miR-106b-25/miR-17-92 clusters: polycistrons with oncogenic roles in hepatocellular carcinomamiR-18a downregulates DICER1 and promotes proliferation and metastasis of nasopharyngeal carcinomadbDEMC: a database of differentially expressed miRNAs in human cancers.Integrated profiling of microRNAs and mRNAs: microRNAs located on Xq27.3 associate with clear cell renal cell carcinoma.
P2860
Q21136339-288B96D0-D270-418A-9E90-7DC9D4B59527Q21198757-EE92428D-48E9-4AFE-8A2C-D511C1027819Q24595141-8456BEC2-DDAF-4876-826E-C4A6DD028E25Q24610339-1A00DC0C-3FEA-4B7F-9140-E5D9925AEC03Q24628683-10985C38-30E5-4FAC-A704-BFFE8D94D9BDQ24646324-14D0C4A5-C014-433A-882B-EACD1069A346Q24648360-3958402A-6449-4B19-B053-FAD46C7749DAQ24655048-AE6299A7-BCC6-4EE4-A7C7-EA229CBF7836Q24655144-D83E5915-70E8-43D5-A899-2C947B9F121AQ24656088-A0AFE501-4896-4EA6-A7E1-6615B5815023Q24656948-845FEEE0-A954-4004-B836-6515B3D4827FQ24657152-04875A18-710A-47E1-8EE9-CF0F5EDEE9E6Q26770381-C0DAE8B9-F7E6-49C4-9911-E29BEF460160Q26772317-4A8263F0-1B8D-43C9-8CA1-AE3C4879449CQ26861699-64287EC7-DD81-47A7-A43B-24FF01A6F44DQ26991956-C1B74D87-971D-460C-AD86-53E16BB74B95Q27005597-9C061CE8-524D-42B6-86E2-2F6A25A6A2B2Q27010206-08504875-22EF-4A4B-88C9-65DB629DC73CQ27011401-C9AEB036-7BAB-48ED-B6B0-2A5307629ECAQ27437642-C3CDFF4A-1A70-48EA-8699-BB4AFE388E7AQ27488310-DD196607-91FD-456D-BECF-F387F608EAC2Q27488345-1503A505-39D4-4BB3-B5CA-B24E6D273075Q28073980-FD536A8B-A29B-43E3-8974-5987FB57DCABQ28275238-A34BD26B-972F-46A8-98BC-74685405A0C3Q28383492-97BCFA48-0B6F-45B1-971D-351AFE85A30EQ28389231-E1077562-6746-4B17-BDD2-AA75AD7A54B3Q28395196-694ACF48-632B-464B-A561-48A9FB4A135EQ28512635-9C5B84F3-CB25-44D8-854D-A630D8B5249DQ28658442-22427CDB-1CDB-4C83-8142-0927DEA492C7Q29547523-9C4485E9-C42D-48E4-8668-048B9F50AF00Q30367369-703DCDD6-2FBF-4DB2-8410-20ED20F58052Q30437444-9D434470-E6C6-4019-9AF8-BB1E2B713F8CQ30439971-1A0ACDEA-4C16-4B18-A815-962339EA9887Q30858748-D16A0F1E-C639-4870-A54D-781852C4316AQ31141908-CE9E8616-C637-4F64-9ECC-62FAA0C112A1Q33625493-C891CB6C-B0D9-41DA-872B-E51C28EDF09EQ33661028-BB9BD941-9059-4411-8F91-EBCBF4D05795Q33756203-0282F67A-EE7C-413F-8840-B354917EC496Q33766768-F7380A10-3CBF-4AD5-BC78-30A992B1C4F8Q33799049-BB751701-6E17-4C52-858B-78C3920AA189
P2860
Downregulation of miR-122 in the rodent and human hepatocellular carcinomas
description
2006 nî lūn-bûn
@nan
2006 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Downregulation of miR-122 in the rodent and human hepatocellular carcinomas
@ast
Downregulation of miR-122 in the rodent and human hepatocellular carcinomas
@en
Downregulation of miR-122 in the rodent and human hepatocellular carcinomas
@nl
type
label
Downregulation of miR-122 in the rodent and human hepatocellular carcinomas
@ast
Downregulation of miR-122 in the rodent and human hepatocellular carcinomas
@en
Downregulation of miR-122 in the rodent and human hepatocellular carcinomas
@nl
prefLabel
Downregulation of miR-122 in the rodent and human hepatocellular carcinomas
@ast
Downregulation of miR-122 in the rodent and human hepatocellular carcinomas
@en
Downregulation of miR-122 in the rodent and human hepatocellular carcinomas
@nl
P2093
P2860
P3181
P356
P1476
Downregulation of miR-122 in the rodent and human hepatocellular carcinomas
@en
P2093
Huban Kutay
Igor Pogribny
Jharna Datta
Kalpana Ghoshal
Samson T Jacob
Shoumei Bai
Tasneem Motiwala
Wendy Frankel
P2860
P3181
P356
10.1002/JCB.20982
P407
P577
2006-10-15T00:00:00Z